BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31100991)

  • 1. Highly specific colon-targeted transformable capsules containing indomethacin immediate-release pellets for colon cancers therapy.
    Yang C; Zhang Y; Cai P; Yuan S; Ma Q; Song Y; Wei H; Wu Z; Wu Z; Qi X
    J Drug Target; 2020 Jan; 28(1):102-110. PubMed ID: 31100991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
    Yehia SA; Elshafeey AH; Elsayed I
    Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC; Sumitra G M
    J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of pectin-based colon-specific pulsatile capsule in vitro and in vivo.
    Liu J; Zhang L; Jia Y; Hu W; Zhang J; Jiang H
    Arch Pharm Res; 2012 Nov; 35(11):1927-34. PubMed ID: 23212634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
    Mughal MA; Iqbal Z; Neau SH
    AAPS PharmSciTech; 2011 Mar; 12(1):77-87. PubMed ID: 21174179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on novel colon position pulsatile capsule and its release in vitro].
    Liu J; Zhang L; Wang C; Yuan P; Xin Y
    Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(23):3127-30. PubMed ID: 21355231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing guar gum for development of "tabs in cap' system of losartan potassium for chronotherapeutics.
    Gangwar G; Kumar A; Pathak K
    Int J Biol Macromol; 2015 Jan; 72():812-8. PubMed ID: 25268456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin.
    Ji C; Xu H; Wu W
    J Drug Target; 2007 Feb; 15(2):123-31. PubMed ID: 17365283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of guargum-based colon-targeted oral drug delivery systems of celecoxib in human volunteers.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):273-80. PubMed ID: 12587957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel plug-controlled colon-specific pulsatile capsule with tablet of curcumin-loaded SMEDDS.
    Huang Y; Tian R; Hu W; Jia Y; Zhang J; Jiang H; Zhang L
    Carbohydr Polym; 2013 Feb; 92(2):2218-23. PubMed ID: 23399280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guar gum as a microbially degradable component for an oral colon delivery system based on a combination strategy: formulation and in vitro evaluation.
    Moutaharrik S; Meroni G; Soggiu A; Foppoli A; Cerea M; Palugan L; Caloni F; Martino PA; Gazzaniga A; Maroni A
    Drug Deliv Transl Res; 2024 Mar; 14(3):826-838. PubMed ID: 37824039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon targeted guar gum compression coated tablets of flurbiprofen: formulation, development, and pharmacokinetics.
    Vemula SK; Bontha VK
    Biomed Res Int; 2013; 2013():287919. PubMed ID: 24260738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon targeted curcumin delivery using guar gum.
    Elias EJ; Anil S; Ahmad S; Daud A
    Nat Prod Commun; 2010 Jun; 5(6):915-8. PubMed ID: 20614824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies on guar gum based formulation for the colon targeted delivery of Sennosides.
    Momin M; Pundarikakshudu K
    J Pharm Pharm Sci; 2004 Sep; 7(3):325-31. PubMed ID: 15576012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery.
    Prasad YV; Krishnaiah YS; Satyanarayana S
    J Control Release; 1998 Feb; 51(2-3):281-7. PubMed ID: 9685926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of budesonide compression-coated tablets for colonic delivery.
    Yehia SA; Elshafeey AH; Sayed I; Shehata AH
    AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping.
    Kumar B; Kulanthaivel S; Mondal A; Mishra S; Banerjee B; Bhaumik A; Banerjee I; Giri S
    Colloids Surf B Biointerfaces; 2017 Feb; 150():352-361. PubMed ID: 27847225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
    Eur J Pharm Sci; 2003 Aug; 19(5):355-62. PubMed ID: 12907286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of indomethacin colon targeted delivery systems using polysaccharides as carriers by applying liquisolid technique.
    Elkhodairy KA; Elsaghir HA; Al-Subayiel AM
    Biomed Res Int; 2014; 2014():704362. PubMed ID: 24971345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.